What Is Apigenin?

Apigenin (4',5,7-trihydroxyflavone) is a flavonoid — a class of plant polyphenols found widely in fruits, vegetables, and herbs. The richest dietary sources include chamomile tea (the single highest source per serving), parsley, celery, dried oregano, and certain citrus fruits. It belongs to the flavone subclass and has been used medicinally for centuries through chamomile preparations, long before its molecular targets were identified.

Unlike many flavonoids that are primarily studied for antioxidant activity, apigenin's value in longevity science is driven by specific enzymatic targets. Its ability to inhibit CD38 — an ectoenzyme responsible for a significant portion of cellular NAD+ degradation — positions it as a natural partner to NAD+ precursors like NMN and NR.

Beyond NAD+ preservation, apigenin has documented anti-inflammatory, anxiolytic, and mild estrogenic-modulating properties. It crosses the blood-brain barrier, which accounts for its central nervous system effects including GABA-A receptor binding and the calming properties traditionally associated with chamomile.

Mechanism of Action

Apigenin is unusual among flavonoids in that its primary value comes not from antioxidant activity but from specific enzyme inhibition. It acts through several distinct biological pathways, each with different levels of evidence and clinical relevance:

• CD38 inhibition: CD38 is one of the primary NAD+-consuming enzymes in the body. Its activity increases with age and chronic inflammation, contributing significantly to age-related NAD+ decline. Research published in Cell Metabolism identified CD38 as a major driver of age-related NAD+ depletion. Apigenin directly inhibits CD38 enzymatic activity, reducing NAD+ degradation and helping maintain cellular NAD+ pools — effectively acting as a NAD+ preservation agent.
• GABA-A receptor modulation: Apigenin binds to benzodiazepine-binding sites on GABA-A receptors, producing mild anxiolytic and sedative effects. Unlike benzodiazepines, apigenin does not appear to cause tolerance, dependence, or next-day grogginess at typical doses. This is the mechanism behind chamomile tea's traditional use as a calming and sleep-promoting beverage.
• Aromatase inhibition: Apigenin inhibits aromatase (CYP19A1), the enzyme that converts testosterone to oestrogen. This is relevant for hormonal balance, particularly in men seeking to maintain testosterone levels or reduce oestrogen dominance. The effect at typical supplement doses is mild compared to pharmaceutical aromatase inhibitors like letrozole or anastrozole, but may be meaningful as part of a broader hormonal optimisation strategy.
• Anti-inflammatory signalling: Apigenin suppresses NF-κB and COX-2 pathways, reducing pro-inflammatory cytokine production including TNF-α and IL-6. This contributes to its broader role in managing chronic low-grade inflammation — a hallmark of biological ageing often termed inflammaging.
• Autophagy promotion: Emerging evidence suggests apigenin may promote cellular autophagy — the process by which cells clear damaged proteins and organelles. This connects to its potential role in cellular maintenance and longevity, though the data is primarily preclinical.

The NMN Stack Rationale

The combination of NMN and apigenin is one of the most widely recommended pairings in longevity supplementation, and the logic is straightforward:

• NMN boosts NAD+ production — it enters the salvage pathway and is converted to NAD+ via NMNAT enzymes, increasing the supply of this critical coenzyme
• Apigenin reduces NAD+ degradation — by inhibiting CD38, it slows the breakdown of NAD+, preserving what the body produces

Think of it as a bathtub analogy: NMN turns the tap on (more NAD+ flowing in), while apigenin plugs the drain (less NAD+ flowing out). Without addressing both sides, supplementing with NMN alone may be partially undermined by elevated CD38 activity — particularly in older individuals or those with chronic inflammation where CD38 expression is highest.

This dual approach is especially relevant after age 40, when CD38 levels rise significantly. Research suggests that CD38 may account for a larger share of age-related NAD+ decline than previously thought — potentially more than reduced synthesis. This makes CD38 inhibition via apigenin a logical first addition to any NAD+ restoration protocol.

Many longevity protocols extend this stack further:

• Resveratrol — a SIRT1 activator that uses NAD+ as a co-substrate, amplifying the downstream benefits of elevated NAD+
• TMG (Trimethylglycine) — supports the increased methylation demand created by NAD+ metabolism, preventing homocysteine accumulation

The theoretical synergy is compelling, though direct human RCT data on the combined stack's longevity outcomes remains limited. This protocol was popularised by David Sinclair and has become a standard starting point in the longevity community.

Evidence Quality

Apigenin has a solid foundation of in vitro and animal data, with a growing but still limited body of human evidence. The strength of evidence varies significantly by endpoint:

• CD38 inhibition: Well-demonstrated in cell and animal models. A 2013 study in The Journal of Biological Chemistry showed apigenin potently inhibits CD38 enzymatic activity. Human pharmacokinetic data confirms oral bioavailability, but specific human trials measuring NAD+ changes from apigenin alone are sparse — most evidence is inferred from mechanistic studies
• Sleep and anxiety: Chamomile extract (standardised for apigenin) has been studied in several small human trials showing modest improvements in sleep quality and generalised anxiety. A 2016 RCT published in Phytomedicine showed long-term chamomile use reduced moderate-to-severe GAD symptoms. A 2019 meta-analysis confirmed chamomile's anxiolytic effects across multiple trials
• Anti-cancer properties: Extensive preclinical data shows apigenin induces apoptosis in various cancer cell lines including breast, prostate, and colon. Human translation is not yet established and these findings should not be interpreted as clinical cancer treatment
• Aromatase inhibition: Demonstrated in vitro; clinical significance at dietary or supplement doses is uncertain. The effect is considerably weaker than pharmaceutical aromatase inhibitors like anastrozole
• Neuroprotection: Animal models suggest apigenin may protect against neurodegeneration via anti-inflammatory and antioxidant mechanisms in the CNS, including reduced microglial activation. Human data is preliminary but the blood-brain barrier permeability of apigenin makes it a compound of interest for brain-ageing research

Dosing & Practical Guidance

Chamomile tea vs pure supplement: A standard cup of chamomile tea contains roughly 3–10 mg of apigenin — far below the doses used in longevity protocols. While chamomile tea offers relaxation benefits (partly from apigenin, partly from other compounds), achieving meaningful CD38 inhibition requires a concentrated supplement. You would need to drink 10–50 cups of chamomile tea daily to match a single 50–100 mg apigenin capsule, which is neither practical nor advisable due to fluid volume.

Dose ranges:

• 50–100 mg/day: The most common dose for CD38 inhibition and sleep support. This is the range most frequently recommended alongside NMN stacks and represents the best balance of efficacy and safety based on available data
• 100–250 mg/day: A moderate dose used by those seeking stronger anti-inflammatory and hormonal effects. Andrew Huberman has popularised 50 mg taken before bed for sleep
• 250–500 mg/day: Used in some aggressive longevity protocols. Higher doses may provide stronger aromatase inhibition but lack robust human safety data at these levels for long-term use

Timing: For sleep benefits, take 50–100 mg approximately 30–60 minutes before bed. For NAD+ preservation as part of an NMN stack, timing is less critical — morning or evening dosing both work. Some practitioners split the dose: a smaller amount with NMN in the morning for CD38 inhibition throughout the day, and the remainder before bed for sleep support via GABA-A modulation.

India sourcing: Apigenin supplements are available in India through imported brands (Swanson, Double Wood, Life Extension) and increasingly through domestic supplement companies. Look for products that specify apigenin content per capsule rather than chamomile extract weight, as standardisation varies widely. Store in a cool, dry place — India's humidity can degrade supplement quality over time.

Bioavailability: Apigenin has relatively low water solubility. Taking it with a small amount of dietary fat (olive oil, nuts, ghee) may improve absorption. Some formulations use micronised or liposomal delivery to enhance bioavailability.

Safety: Apigenin has a long history of safe use through chamomile consumption. At supplement doses (50–500 mg), no serious adverse effects have been reported in human studies. However, due to its aromatase-inhibiting properties, individuals on hormone therapy or with hormone-sensitive conditions should consult a physician before supplementing at higher doses. Pregnant and breastfeeding women should avoid supplemental apigenin beyond dietary intake from food sources.

Drug interactions: Apigenin may inhibit certain cytochrome P450 enzymes (CYP1A2, CYP2C9), potentially affecting the metabolism of medications processed through these pathways. If you are on prescription medication, consult your doctor before adding apigenin to your regimen.

Biomarker Connections

Apigenin's effects can be contextualised through several measurable biomarkers, making it possible to track whether supplementation is producing the intended biological changes:

• NAD+ levels (whole blood): The primary target — apigenin aims to preserve NAD+ by reducing CD38-mediated degradation. Intracellular NAD+ testing is becoming available through specialised labs in India and internationally
• hs-CRP and inflammatory markers: Apigenin's NF-κB suppression may contribute to lower systemic inflammation, measurable via high-sensitivity C-reactive protein
• Testosterone and oestradiol: Relevant for those using apigenin partly for its aromatase-inhibiting properties. Monitor free testosterone and E2 levels if hormonal modulation is a goal
• Sleep quality metrics: Subjective (Pittsburgh Sleep Quality Index) or objective (wearable-derived sleep staging data from devices like Oura Ring or WHOOP) can track the GABA-A modulation effects over time
• Homocysteine: When stacking apigenin with NMN, monitoring homocysteine helps assess whether the increased NAD+ metabolism is creating methylation stress — an indicator for adding TMG to the protocol

For individuals in India, NAD+ testing can be accessed through functional medicine labs and some advanced diagnostic centres in major cities like Mumbai, Delhi, and Bangalore. Pairing apigenin supplementation with periodic biomarker testing — ideally every 3–6 months — allows for data-driven protocol adjustments rather than relying solely on subjective response.

Who Should Consider Apigenin?

Apigenin is most relevant for individuals who fall into one or more of these categories:

• NAD+ stack users: Anyone taking NMN or NR who wants to maximise the return on their NAD+ precursor investment by reducing CD38-mediated degradation
• Sleep optimisers: Those seeking a non-habit-forming sleep aid that works through GABA-A modulation rather than melatonin receptor agonism
• Anti-ageing protocols: Individuals over 40 looking to address the accelerating NAD+ decline driven by rising CD38 levels
• Inflammation management: Those with elevated hs-CRP or chronic low-grade inflammation who want a gentle, well-tolerated anti-inflammatory flavonoid

Apigenin is generally not necessary for younger individuals (<30) with low inflammation and no sleep issues, as CD38 levels are typically lower and NAD+ production is still robust at younger ages.

Frequently Asked Questions

Related Terms